Evidence suggests that intraarticular corticosteroids are effective (short term) and safe (long term)

Published:October 20, 2022DOI:
      In a meta-analysis recently published in Osteoarthritis and Cartilage, Donovan et al.
      • Donovan R.
      • Edwards T.
      • Judge A.
      • et al.
      Effects of recurrent intra-articular corticosteroid injections for osteoarthritis at three months and beyond.
      stated that ‘recurrent intraarticular corticosteroids (IACS) often provide inferior (or non-superior) longer-term symptom relief compared with other injectables’. However, after carrying out meta-analyses of treatments for osteoarthritis (OA) or reviewing comprehensive ones, many guidelines committees have recommended IACS, at least conditionally, for the treatment of OA. What is the evidence supporting the efficacy and safety of IACS, and how can we make sense of these conflicting findings/recommendations?


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Osteoarthritis and Cartilage
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Donovan R.
        • Edwards T.
        • Judge A.
        • et al.
        Effects of recurrent intra-articular corticosteroid injections for osteoarthritis at three months and beyond.
        Osteoarthritis Cartilage. 2022; (Published online)
        • Richette P.
        • Latourte A.
        All that glistens is not gold.
        Osteoarthritis Cartilage. 2022; (Published online)
        • Bisicchia S.
        • Bernardi G.
        • Tudisco C.
        HYADD 4 versus methylprednisolone acetate in symptomatic knee osteoarthritis: a single-centre single blind prospective randomised controlled clinical study with 1-year follow-up.
        Clin Exp Rheumatol. 2016; 34: 857-863
        • Davalillo C.Á.T.
        • Vasavilbaso C.T.
        • Álvarez J.M.N.
        • et al.
        Clinical efficacy of intra-articular injections in knee osteoarthritis: a prospective randomized study comparing hyaluronic acid and betamethasone.
        Open Access Rheumatol. 2015; 7: 9-18
        • Jüni P.
        • Hari R.
        • Rutjes A.W.S.
        • et al.
        Intra-articular corticosteroid for knee osteoarthritis.
        Cochrane Database Syst Rev. 2015; 2015
        • O'Neill T.W.
        • Parkes M.J.
        • Maricar N.
        • et al.
        Synovial tissue volume: a treatment target in knee osteoarthritis (OA).
        Ann Rheum Dis. 2016; 75: 84-90
        • Bodick N.
        • Lufkin J.
        • Willwerth C.
        • et al.
        An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.
        J Bone Joint Surgery — American. 2014; 97: 877-888
        • McAlindon T.E.
        • LaValley M.P.
        • Harvey W.F.
        • et al.
        Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis a randomized clinical trial.
        JAMA, J Am Med Assoc. 2017; 317: 1967-1975
        • Bucci J.
        • Chen X.
        • LaValley M.
        • et al.
        Progression of knee osteoarthritis with use of intraarticular glucocorticoids versus hyaluronic acid.
        Arthritis Rheumatol. 2022; 74: 223-226
        • Latourte A.
        • Rat A.C.
        • Omorou A.
        • et al.
        Do glucocorticoid injections increase the risk of knee osteoarthritis progression over 5 years?.
        Arthritis Rheumatol. 2022; 74: 1343-1351